Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic Prophylaxis in Oncological Breast Surgery
NCT02809729Completed
- Start
- Jan 2015
- Primary completion
- Apr 2017
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Randomised, double-blind trial in surgical site infection (SSI) comparing Placebo with Cefazolin (2 arms). Primary endpoint: Surgical Site Infection in Oncologic Breast Surgery at 30 days. Started Jan 2015; status: completed.
02
Drugs
cefazolin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT02809729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02809729.